Skip to main content

Roundup Weed Killer Lawsuits going Strong

Roundup Weed Killer Lawsuits going Strong

Roundup Weed Killer Lawsuits going Strong

Introduction

Roundup Weed Killer: MDL No. 2741, in re: Roundup Products Liability Litigation was created in October 2016, before U.S. District Judge Vince Chhabria, in the Northern District of California. The defendant, Monsanto, will face the first trial on June 18, 2018, in the Superior Court for the County of San Francisco. About 3,500 plaintiffs now represent nearly 2,200 cases filed in state and federal courts.

Another product liability lawsuit has been filed by a man from Arizona under this MDL, who alleges that Monsanto’s Roundup was the reason for his diagnosis of non-Hodgkin’s lymphoma. The plaintiff further stated that he used Roundup on his property for over 20 years, without receiving any warning of the potential development of non-Hodgkin’s lymphoma and holds Monsanto responsible for the failure to warn him and other consumers.  

The Daubert Hearings, scheduled earlier for December 2017, are now set to begin on March 5, in order to consider the admissibility of expert witness testimony on the link between Roundup and non-Hodgkin’s lymphoma, a decision taken by Judge Chhabria.

The Judge also bifurcated the proceedings to first address the general causation link before considering any case-specific issues about whether the weed killer caused any individual plaintiff’s diagnosis.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!